Multivesicular body subunit 12B (MVB12B) overexpression represses proliferation and migration in bladder urothelial carcinoma
MVB12B functions as a tumor-suppressive role in BLCA and is associated with good prognosis in BLCA patients. MVB12B can be used as a potential biomarker for prognosis and therapeutic of BLCA.
Authors
- X Li
- Caize Cen (ORCID: https://orcid.org/0000-0003-2325-7717)
- Qisheng Su (ORCID: https://orcid.org/0000-0003-3858-1018)
- Wuning Mo
- Rongxin Li
- Faquan Lin
Institutions
- Guangxi Medical University (CN)
- Guangxi University of Chinese Medicine (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/tcr-2025-1498
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00